	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	1956.66	1901.61	1468.15	2.9%	33.3%
Operating Profit Qtr	511.62	499.13	381.53	2.5%	34.1%
Net Profit Qtr	319.00	238.80	251.54	33.6%	26.8%
Earning Per Share Adjusted latest Qtr	3.28	2.46	2.59	33.3%	26.6%

* Consolidated data

Detailed Results

Max Healthcare Institute Ltd.

20 May 2025, 02:54PM

1177.90

1.13%

Company Update

Max Healthcare Institute Ltd - 543220 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release - Max Healthcare Q4 revenue soars by +29% YoY to INR 2,429 Cr; Operating EBITDA rises to INR 632 Cr, +26% YoY; PAT grows by +21% YoY to INR 376 Cr

pdf

Max Healthcare Institute Ltd.

20 May 2025, 02:43PM

1177.90

1.13%

Board Meeting

Max Healthcare Institute Ltd - 543220 - Board Meeting Outcome for Meeting Held On May 20, …

BSE India

Outcome of Board Meeting held on May 20, 2025

pdf

Natco Pharma Ltd.

20 May 2025, 02:16PM

870.00

2.11%

Company Update

Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Earnings Call with Investors / Analysts at on Thursday, the 29th May 2025 at 11:00 AM IST to discuss the Audited Financial Results of the Company for the quarter and year ended 31st March, 2025

pdf

Gland Pharma Ltd.

20 May 2025, 01:50PM

1556.60

3.89%

Company Update

Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Investor Meet Intimation - 23052025

pdf

Nifty MidSmall Healthcare PB	6.1
Nifty MidSmall Healthcare PE	45.5
Nifty MidSmall Healthcare DIV	0.4
Nifty MidSmall Healthcare EPS	905.6